Iproclozide

Iproclozide (trade names Sursum, Sinderesin) is an irreversible and selective monoamine oxidase inhibitor (MAOI) of the hydrazine chemical class that was used as an antidepressant, but has since been discontinued.^[2] It has been known to cause fulminant hepatitis and there have been at least three reported fatalities due to administration of the drug.^[3][4]

Iproclozide

Clinical data
Routes of administration	Oral
ATC code	N06AF06 (WHO)
Legal status
Legal status	BR: Class C1 (Other controlled substances)[1] In general: uncontrolled
Identifiers
IUPAC name 2-(4-chlorophenoxy)-N-isopropyl-acetohydrazide
CAS Number	3544-35-2 Y
PubChem CID	19063
ChemSpider	17998 Y
UNII	1II9D6CB3J
KEGG	D07338 Y
ChEMBL	ChEMBL91238 Y
CompTox Dashboard (EPA)	DTXSID70188925
ECHA InfoCard	100.020.536
Chemical and physical data
Formula	C11H15ClN2O2
Molar mass	242.70 g·mol−1
3D model (JSmol)	Interactive image
SMILES Clc1ccc(OCC(=O)NNC(C)C)cc1
InChI InChI=1S/C11H15ClN2O2/c1-8(2)13-14-11(15)7-16-10-5-3-9(12)4-6-10/h3-6,8,13H,7H2,1-2H3,(H,14,15) Y Key:GGECDTUJZOXAAR-UHFFFAOYSA-N Y
(verify)

See also

• Hydrazine (antidepressant)